Up a level |
Pushpakom, Sudeep ORCID: 0000-0002-6682-4235, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Taylor, Claire, Foster, Terry, Spowart, Cath, García-Fiñana, Marta, Kemp, Graham J ORCID: 0000-0002-8324-9666, Jaki, Thomas, Khoo, Saye, Williamson, Paula ORCID: 0000-0001-9802-6636 et al (show 2 more authors)
(2019)
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.